By a News Reporter-Staff News Editor at Cancer Weekly -- New research on Oncology is the subject of a report. According to news reporting originating in Rockville, Maryland, by NewsRx journalists, research stated, "Much of the extant literature addressing the psychosocial aspects of BRCA1/2 mutation testing and risk management aggregates mutation carriers of all ages in study recruitment, data analysis, and interpretation. This analytic strategy does not adequately address the needs of the youngest genetic testing consumers, i.e., women aged 18-25."
The news reporters obtained a quote from the research from National Cancer Institute, "Despite low absolute cancer risk estimates before age 30, BRCA1/2 mutation-positive women aged 18-25 feel vulnerable to a cancer diagnosis but find themselves in a management quandary because the clinical utility of screening and prevention options are not yet well defined for such young carriers. We present three cases, selected from a larger study of 32 BRCA1/2 mutation-positive women who completed or considered genetic testing before age 25, to demonstrate the unique developmental, relational and temporal influences, as well as the challenges, experienced by very young BRCA mutation-positive women as they complete genetic testing and initiate cancer risk management. The first case describes the maturation of a young woman whose family participated in a national cancer registry. The second addresses the experiences and expectations of a young woman who completed genetic testing after learning that her unaffected father was a mutation carrier. The third case highlights the experiences of a young woman parentally bereaved in childhood, who presented for genetic counseling and testing due to intense family pressure. Together, these cases suggest that BRCA1/2-positive women aged 18-25 are challenged to reconcile their burgeoning independence from their families with risk-related support needs. Loved ones acting in ways meant to care for these young women may inadvertently apply pressure, convoluting family support dynamics and autonomous decision-making."
According to the news reporters, the research concluded: "Ongoing support from competent healthcare professionals will enable these young women to remain informed and receive objective counsel about their risk-management decisions."
For more information on this research see: A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25. Journal of Genetic Counseling, 2013;22(1):27-38. Journal of Genetic Counseling can be contacted at: Springer, 233 Spring Street, New York, NY 10013, USA. (Springer - www.springer.com; Journal of Genetic Counseling - www.springerlink.com/content/1059-7700/)
Our news correspondents report that additional information may be obtained by contacting L.M. Hoskins, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States (see also Oncology).
The publisher of the Journal of Genetic Counseling can be contacted at: Springer, 233 Spring Street, New York, NY 10013, USA.
Keywords for this news article include: Cancer, Maryland, Genetics, Oncology, Rockville, United States, North and Central America.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC